Medplus Health Services Ratios

Medplus Health Services Ltd Ratios

The Medplus Health Services Ltd Ratios page provides a complete fundamental analysis of Medplus Health Services Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Medplus Health Services Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Medplus Health Services Ltd (NSE: MEDPLUS, BSE: 543427) is currently trading at ₹830.50, with a market capitalization of ₹101.61B. As a major player in the Retail trade sector and Drugstore chains industry, Medplus Health Services Ltd remains a key stock for fundamental analysis using Medplus Health Services Ltd Ratios.

Medplus Health Services Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Medplus Health Services Ltd P/E ratio currently stands at 60.65, making it one of the most tracked metrics in Medplus Health Services Ltd Ratios.

Historically, the Medplus Health Services Ltd P/E ratio has shown strong fluctuations:

• 2024: 60.65
• 2023: 126.39
• 2022: 156.56
• 2021: 118.15
• 2020: 0

The decline in Medplus Health Services Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Medplus Health Services Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 5.22.

Historical P/B trend:

• 2024: 5.22
• 2023: 5.22
• 2022: 5.20
• 2021: 8.47

Medplus Health Services Ltd is trading at a premium to its book value, indicating strong market confidence.

Price to Sales Ratio (P/S)

The Medplus Health Services Ltd P/S ratio currently stands at 1.49, an important part of Medplus Health Services Ltd Ratios for revenue valuation.

Historical P/S ratio:

• 2024: 1.49
• 2023: 1.47
• 2022: 1.71
• 2021: 3

The rising Medplus Health Services Ltd P/S ratio indicates improved revenue valuation by investors.

Medplus Health Services Ltd Price to Cash Flow Ratio (P/CF)

The Medplus Health Services Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 16.44.

Historical Medplus Health Services Ltd Price to Cash Flow Ratio:

• 2024: 16.44
• 2023: 52.62
• 2022: 70.31
• 2021: 66.78
• 2020: 0

The declining Medplus Health Services Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Medplus Health Services Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Medplus Health Services Ltd EV currently stands at ₹97.96B, representing the total company valuation including debt.

Historical EV trend:

• 2024: 97.96B
• 2023: 91.19B
• 2022: 84.03B
• 2021: 114.76B

Medplus Health Services Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.

EV/EBITDA Ratio

The Medplus Health Services Ltd EV/EBITDA ratio is currently 20.01, a key metric in Medplus Health Services Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

• 2024: 20.01
• 2023: 25.60
• 2022: 31.40
• 2021: 41.95

Stable Medplus Health Services Ltd EV/EBITDA indicates balanced valuation.

Medplus Health Services Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Medplus Health Services Ltd D/E ratio is currently 0.64, reflecting leverage and financial stability.

Historical D/E:

• 2024: 0.64
• 2023: 0.64
• 2022: 0.60
• 2021: 0.57

Medplus Health Services Ltd maintains moderate leverage with manageable risk.

Return on Equity (ROE %)

The Medplus Health Services Ltd ROE currently stands at 9.06%, showing profitability and capital efficiency.

Historical ROE:

• 2024: 9.06
• 2023: 4.27
• 2022: 3.42
• 2021: 8.92

Declining ROE indicates pressure on profitability.

Medplus Health Services Ltd Ratios Analysis Summary

The Medplus Health Services Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Medplus Health Services Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Medplus Health Services Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.